About us

Founded in 1990 and located in the university town of Freiburg in Germany, Pharmametrics is a healthcare consulting company focusing on scientific evidence-based research in epidemiology, health economics & outcomes research (HEOR), health technology assessments (HTA) and market access. Pharmametrics GmbH is privately owned and has been offering a rich array of research, consulting and advisory services for the last 25 years.


With a network of excellent expertise worldwide Pharmametrics GmbH is committed to producing high quality, scientifically rigorous information, databases, portals and software solutions to support our clients’ strategic decision making. This commitment is fulfilled through working closely with clients during all phases of a project to ensure that the deliverables achieve the objective to support their strategic decision making.

Products and Services

Pharmametrics offers a rich array of research, consulting and advisory services including

  • Epidemiological reports & large databases,
  • Health economic & outcomes assessments & modelling,
  • Health technology assessments (HTA).

For almost 25 years, Pharmametrics has provided evidence-based data, information, reports, databases and analytics to the pharmaceutical industry.

Our deliverables support our clients by providing:

  • epidemiological data for early decision-making
    (portfolio analysis, potential market assessment, forecasting, preparation of clinical trial design)
  • epidemiological, economic & outcomes data for an optimal launch programme (assessment of target population, treatment algorithms, outcomes, health economic modelling, preparation of submission/value dossiers/HTAs, support of pricing & reimbursement)


Epidemiological Reports & Databases

Our deliverables in the field of epidemiology are based on rigorous methodologies and comprise:

  • Systematic literature reviews
  • Definitions, classifications
  • Incidence, prevalence
  • Target population
  • Treatment patterns
  • Current Clinical Practice
  • Patient pathways
  • Patient segmentation
  • Assessment of unmet need
  • Disease-specific databases
  • Bibliographies
  • Trends, Forecasts
  • Portfolio analysis

Diseases Covered

Oncology Haematology

  • Acute myeloid leukemia (AML)
  • Multiple myeloma (MM)
  • Chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
  • Mantle cell lymphoma (MCL)
  • Diffuse large B-cell lymphoma (DLBCL)
  • Follicular lymphoma (FL)
  • Myelodysplastic syndrome (MDS)
  • Other indolent non-Hodgkin´s lymphoma (iNHL)s

Oncology Solid Cancers

  • Basal cell carcinoma
  • Glioblastoma
  • Head & Neck (SCCHN)
  • Neuroendocrine tumours (NETs) / Carcinoids
  • Cushing’s disease/Syndrome
  • Acromegaly
  • Non-Small Cell Lung Cancer (NSCLC)
  • Prostate Cancer (PC)
  • Hepatocellular Cancer (HCC)
  • Pancreatic cancer
  • Malignant melanoma

Infectious diseases

  • Hepatitis C
  • Nosocomial infections
  • MRSA
  • Skin and soft tissue infections (SSI)
  • Fungal infections / mycoses

Mental & neurological diseases

  • Alzheimer’s disease (AD)
  • Parkinson’s disease (PD)
  • Multiple sclerosis (MS)
  • Bipolar disorder
  • Anxiety
  • Depression

Circulatory & metabolic diseases

  • Acute coronary syndromes (ACS)
  • Cardiac surgery
  • Stroke
  • Intracranial haemorrhage (ICH)
  • Diabetes mellitus (DM)
  • Diabetic neuropathy
  • Diabetic foot ulcers (DFU)

Autoimmune diseases

  • Psoriasis
  • Psoriatic arthritis (PsA)
  • Rheumatoid arthritis (RA)
  • Systemic lupus erythematosus (SLE)
  • Ankylosing spondylitis (AS)
  • Crohn’s disease (CD)
  • Ulcerative colitis (UC)

Rare diseases

  • Ataxia and cerebellar degeneration
  • Friedreich’s ataxia
  • Cystic fibrosis
  • Haemophilia

Health Economics and Outcome Research (HEOR) & Health Technology Assessments (HTAs)

Pharmametrics provides health economics, outcomes research, and technology assessment services to its clients. The key focus is the analysis, evaluation and preparation of solid information and data, concepts and models that entitle our clients in demonstrating evidence-based value of their products.

The Pharmametrics team has extensive experience in Health Economic Modelling: Discrete-Event Simulation (DES), Markov Models, Stochastic Models, Cost-effectiveness Analyses (CEAs), Budget Impact Models (BIM), Cost of Illness. In addition, Pharmametrics has participated in the preparation of various value dossiers for submission to regulatory authorities. All of these projects are conducted on a proprietary basis for our clients. The assessments and tools produced by Pharmametrics in the field of HEOR and HTA comprise:

  • Systematic literature reviews
  • Outcomes analysis
  • Retrospective database analyses
  • Analyses of sickness fund databases
  • Identification & analysis of patient-level databases
  • Health Economic Modelling
  • Cost-Effectiveness Analyses (CEA)
  • Cost of Illness Assessment (COI)
  • Budget Impact Analyses/Models (BIM)
  • Assessment of resource use & cost
  • Assessment of Patient Pathways
  • Assessment of Treatment Patterns
  • Preparation of Global Value Dossiers
  • Assessment of Product Value Propositions
  • Preparation of submission assessments
    (i.e. AMNOG: Value Dossiers, NICE: Technology Assessments)
  • Pricing & Reimbursement

Large Disease Databases

Pharmametrics has developed several evidence-based databases comprising epidemiology, health economic, outcomes and treatment data. Please contact us for further detail.



We are currently developing several disease and Health Technology Assessment (HTA) Portals. Please contact us for further detail.




Bristol-Myers Squibb




Eli Lilly



Novo Nordisk







Contact us

Send me a copy

Pharmametrics GmbH

Tennenbacherstraße 9

79106 Freiburg



Tel +49 761 207250

Fax +49 761 2072525

Business lounge

Coming soon


Pharmametrics GmbH
Tennenbacherstraße 9
79106 Freiburg

Tel +49 761 207250
Fax +49 761 207251


E-Mail: info@pharmametrics.com
Managing Director: Angela Kempel-Waibel

Registration court: Amtsgericht Freiburg
Registry number: HRB 3710

VAT-ID Number according to § 27a VAT act:
VAT Id Nr: DE142111329

Responsible for Content according to § 10, 3 MDStV:
Angela Kempel-Waibel

Konzeption und Gestaltung

punkt KOMMA Strich



Limitation of liability for internal content

The content of our website has been compiled with meticulous care and to the best of our knowledge. However, we cannot assume any liability for the up-to-dateness, completeness or accuracy of any of the pages. In spite of careful supervision of the contents we are not liable for the contents of external links. The content of linked pages is the exclusive responsibility of their operators.

Pursuant to section 7, para. 1 of the TMG (Telemediengesetz – Tele Media Act by German law), we as service providers are liable for our own content on these pages in accordance with general laws. However, pursuant to sections 8 to 10 of the TMG, we as service providers are not under obligation to monitor external information provided or stored on our website. Once we have become aware of a specific infringement of the law, we will immediately remove the content in question. Any liability concerning this matter can only be assumed from the point in time at which the infringement becomes known to us.

Limitation of liability for external links

Our website contains links to the websites of third parties (“external links”). As the content of these websites is not under our control, we cannot assume any liability for such external content. In all cases, the provider of information of the linked websites is liable for the content and accuracy of the information provided. At the point in time when the links were placed, no infringements of the law were recognisable to us. As soon as an infringement of the law becomes known to us, we will immediately remove the link in question.


The content and works published on this website are governed by the copyright laws of Germany. Any duplication, processing, distribution or any form of utilisation beyond the scope of copyright law shall require the prior written consent of the author or authors in question.

Data protection

A visit to our website can result in the storage on our server of information about the access (date, time, page accessed). This does not represent any analysis of personal data (e.g., name, address or e-mail address). If personal data are collected, this only occurs – to the extent possible – with the prior consent of the user of the website. Any forwarding of the data to third parties without the express consent of the user shall not take place.

We would like to expressly point out that the transmission of data via the Internet (e.g., by e-mail) can offer security vulnerabilities. It is therefore impossible to safeguard the data completely against access by third parties. We cannot assume any liability for damages arising as a result of such security vulnerabilities.

The use by third parties of all published contact details for the purpose of advertising is expressly excluded. We reserve the right to take legal steps in the case of the unsolicited sending of advertising information; e.g., by means of spam mail.